Clovis Oncology, Inc. (NASDAQ:CLVS) Posted Basic Consolidated EPS Of $-9.7946

0

Clovis Oncology, Inc. (NASDAQ:CLVS) annual basic consolidated EPS was $-9.7946 for the period ended 2015-12-31. The basic consolidated EPS was $-9.7946 for the quarter ended 2015-12-31.

EPS from continuing operations

Clovis Oncology, Inc. (NASDAQ:CLVS)’s basic EPS from continuing operations was $-9.7946 for the fiscal year 2015-12-31. For the quarter ended 2015-12-31 it stood at $-9.7946

EPS contribution from parent

From the parent company Clovis Oncology, Inc. (NASDAQ:CLVS) posted basic EPS of $-9.7946 for the fiscal ended 2015-12-31. For the quarter that ended on 2015-12-31 the figure stood at $-9.7946.

Basic net EPS

The Basic net EPS of Clovis Oncology, Inc. (NASDAQ:CLVS) was $-9.79 for the period ended 2015-12-31. The figure stood at $-9.79 for the quarter that ended 2015-12-31.

Consolidated diluted EPS

The consolidated diluted EPS for the fiscal year 2015-12-31 stood at $-9.7946. While the figure for the quarter ended 2015-12-31 stood at $-9.7946.

Basic diluted EPS

The diluted EPS from continuing operation of Clovis Oncology, Inc. (NASDAQ:CLVS) stood at $-9.7946 for the fiscal 2015-12-31. The figure for the quarter ended 2015-12-31 stood at $-9.7946

Net diluted EPS

The Net diluted EPS was $-9.79 for the fiscal 2015-12-31. The figure for the quarter ended 2015-12-31 stood at $-9.79.

Diluted EPS from parent

Clovis Oncology, Inc. (NASDAQ:CLVS) diluted EPS from the parent company for the fiscal 2015-12-31 was $-9.7946. The figure for the quarter ended 2015-12-31 was $-9.7946

The net basic EPS was $-9.79 for fiscal 2015-12-31. The figure for the quarter ended 2015-12-31 was $-9.79

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 10 times, 1 visits today)